Go to The Journal of Clinical Investigation
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
  • Physician-Scientist Development
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Immunology
    • Metabolism
    • Nephrology
    • Oncology
    • Pulmonology
    • All ...
  • Videos
  • Collections
    • In-Press Preview
    • Resource and Technical Advances
    • Clinical Research and Public Health
    • Research Letters
    • Editorials
    • Perspectives
    • Physician-Scientist Development
    • Reviews
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • In-Press Preview
  • Resource and Technical Advances
  • Clinical Research and Public Health
  • Research Letters
  • Editorials
  • Perspectives
  • Physician-Scientist Development
  • Reviews
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Transfers
  • Advertising
  • Job board
  • Contact
Exercise and metformin counteract altered mitochondrial function in the insulin-resistant brain
Gregory N. Ruegsegger, Patrick M. Vanderboom, Surendra Dasari, Katherine A. Klaus, Parijat Kabiraj, Christina B. McCarthy, Claudia F. Lucchinetti, K. Sreekumaran Nair
Gregory N. Ruegsegger, Patrick M. Vanderboom, Surendra Dasari, Katherine A. Klaus, Parijat Kabiraj, Christina B. McCarthy, Claudia F. Lucchinetti, K. Sreekumaran Nair
View: Text | PDF
Research Article Endocrinology Metabolism

Exercise and metformin counteract altered mitochondrial function in the insulin-resistant brain

  • Text
  • PDF
Abstract

Insulin resistance associates with increased risk for cognitive decline and dementia; however, the underpinning mechanisms for this increased risk remain to be fully defined. As insulin resistance impairs mitochondrial oxidative metabolism and increases ROS in skeletal muscle, we considered whether similar events occur in the brain, which — like muscle — is rich in insulin receptors and mitochondria. We show that high-fat diet–induced (HFD-induced) brain insulin resistance in mice decreased mitochondrial ATP production rate and oxidative enzyme activities in brain regions rich in insulin receptors. HFD increased ROS emission and reduced antioxidant enzyme activities, with the concurrent accumulation of oxidatively damaged mitochondrial proteins and increased mitochondrial fission. Improvement of insulin sensitivity by both aerobic exercise and metformin ameliorated HFD-induced abnormalities. Moreover, insulin-induced enhancement of ATP production in primary cortical neurons and astrocytes was counteracted by the insulin receptor antagonist S961, demonstrating a direct effect of insulin resistance on brain mitochondria. Further, intranasal S961 administration prevented exercise-induced improvements in ATP production and ROS emission during HFD, supporting that exercise enhances brain mitochondrial function by improving insulin action. These results support that insulin sensitizing by exercise and metformin restores brain mitochondrial function in insulin-resistant states.

Authors

Gregory N. Ruegsegger, Patrick M. Vanderboom, Surendra Dasari, Katherine A. Klaus, Parijat Kabiraj, Christina B. McCarthy, Claudia F. Lucchinetti, K. Sreekumaran Nair

×

Figure 6

Metformin reverses brain insulin resistance and impairments in mitochondrial function accompanying HFD.

Options: View larger image (or click on image) Download as PowerPoint
Metformin reverses brain insulin resistance and impairments in mitochond...
(A) Insulin receptor and IDE protein expression did not differ between groups (n = 7). (B) Ex vivo treatment of isolated hippocampal tissue with 10 nM insulin for 10 minutes showed that insulin failed to induce AKT and GSK-3β phosphorylation in HFD-AL and HFD-R mice, which was corrected in HFD-MFN (n = 7). (C and D) Citrate synthase (CS) (C) and cytochrome c oxidase (COX) (D) activities were lower in the hippocampus of HFD-AL and HFD-R, which was corrected in HFD-MFN (n = 9–10). (E) Mitochondrial ATP production rate (MAPR) in isolated cerebral mitochondria was lower in HFD-AL and HFD-R, which was corrected in HFD-MFN (n = 9–10). (F) ROS emission in isolated cerebral mitochondria was greater in HFD-AL and HFD-R, which was corrected in HFD-MFN (n = 9–10). (G) SOD2 activity in the cerebrum was lower in HFD-AL and HFD-R, which was normalized in HFD-MFN (n = 7). (H and I) MAPR (H) and ROS emission (I) negatively and positively associated with the glycemic response, respectively, during and insulin tolerance test. Data represent means ± SEM and were analyzed with mixed model analysis and Student’s t test post hoc comparisons (A and C–G), paired t test (B), or Pearson correlation test (H and I); *P < 0.05; **P < 0.01.

Copyright © 2026 American Society for Clinical Investigation
ISSN 2379-3708

Sign up for email alerts